Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Sowmya Kaur is the Executive Vice President and BU Head Clinical APAC/Russia at Navitas Life Sciences with a successful track record of building and leading Clinical Development engagements across Emerging Markets with successful delivery of portfolio of projects.
Articles by Sowmya Kaur, Brand Insights Contributor, Executive VP, Navitas Clinical Research and Head of Clinical – APAC, Navitas Life Sciences
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
2
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
5